Sana Biotechnology, Inc. SANA 深 滬
等待開盤 09-11 09:30:00 美东时间
2.91
-0.110
-3.64%
華盛通- 最 高3.04
- 今 開3.03
- 成交量 382.99万股
- 最 低 2.865
- 昨 收 3.02
- 總市值 6.58亿
- 52周最高 7.30
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.26
- 委 比 30.41%
- 總股本 2.26亿
- 歷史最高 44.60
- 量 比 1.33
- 振 幅 5.79%
- 歷史最低 1.26
- 每 手 1
- 風險率 0.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sana Biotechnology Board Member Resigns Effective August 29
Sana Biotechnology ( ($SANA) ) has issued an update. On August 28, 2025, Mary A...
08-30 04:28
医疗板块回暖+中报营收利润双高增，归创通桥（2190.HK）凭什么领跑创新械企？
2025年以来，沉寂已久的港股医药行业迎来强势反弹。富途显示，今年恒生医疗保健指数累计涨幅已突破100%，不仅如同一记强心针点燃市场热情，更引发市场对行业走势的...
08-27 11:40
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sana Biotechnology, Inc. announced the completion of a stock sale, issuing 3,358,208 shares at $3.35 per share, raising approximately $86.3 million before expenses. Morgan Stanley, Goldman Sachs, BofA Securities, and TD Cowen acted as joint book-running managers. The offering followed the exercise of underwriters' option post an August 8 public offering. SEC filings and prospectus details were provided, with copies available from the listed firms...
08-20 20:05
Sana Biotechnology Non-GAAP EPS of -$0.39
Sana Biotechnology press release (NASDAQ:SANA): Q2 Non-GAAP EPS of -$0.39. Cash, cash equivalents, and marketable securities as of June 30, 2025 were $72.7 million compared to $152.5 million as of Dec...
08-12 04:45
Sana Biotechnology Q2 Adj. EPS $(0.16) Beats $(0.21) Estimate
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.21) by 22.71 percent. This is a 50 percent increase over losses of $(0.32) per share from
08-12 04:17
Why Is Sana Biotechnology Stock Down 25% Today?
Sana Biotechnology stock fell hard on Thursday after the company announced the ...
08-07 21:28
Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35
Sana Biotechnology (NASDAQ:SANA) priced its underwritten public offering of ~20.89M shares at $3.35 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase ~1.5M s...
08-07 12:52
叙利亚达成多项国际经济合作 基建和电力大项目助经济复苏
①叙利亚民航总局与卡塔尔、土耳其和美国企业组成的联合体签署了谅解备忘录，将投资逾40亿美元改造大马士革国际机场； ②叙利亚政府与国际财团签署了一份价值70亿美元的谅解备忘录，旨在共同开发运营发电项目； ③叙利亚与土耳其成立了联合商业委员会以促进两国经济合作，并推动贸易和投资。
08-07 11:31
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
<p>Sana Biotechnology has initiated a $75 million public offering of its common stock, with an option for underwriters to purchase an additional $11.25 million. Morgan Stanley, Goldman Sachs, BofA Securities, and TD Cowen are leading the offering. The transaction is subject to market conditions and SEC requirements. Sana aims to provide engineered cell therapies for patients across its facilities in Seattle, Cambridge, and South San Francisco.</p...
08-06 20:38
Sana Biotechnology Study Published In NEJM Shows HIP-Modified Islet Cells Function Without Immunosuppression In Type 1 Diabetes Patient
Data Demonstrate that Sana's Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 DiabetesStudy Establishes Ability to
08-04 23:35
